RH Blood Group System

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 14

The Rh Blood Group System

Overview
 Discovered by Landsteiner and Weiner
in 1940 when deliberately immunizing
guinea and rabbits with the red cells of
rhesus monkeys
 Sera from the immunized animals
agglutinated not only rhesus monkeys,
but, the red cells of 85% of humans
 It is now known that the animal anti-
rhesus antibodies are not identical in
specificity to those of human origin.
 Term Rh-positive indicates only one
specific antigen, Rh0 (D)
 In 1941 recognized the relationship
between Hemolytic Disease of the Fetus
and Newborn (Erythroblastosis fetalis)
and Rh blood group incompatibility
between mother and fetus.
Models of Inheritance
 Blood group antibodies recognize gene
products, not the genes directly
 Gene products are always a combination
of those inherited from both parents
 Antibodies directed to the products of
allelic genes (antithetical antibodies)
 Absence of the product of any gene of a
known allelic pair implies homozygosity
for its allele
 An allele with no detectable product is
an amorph
 The expression of a gene product may be
altered by the influence of another gene
Nomenclature
Rh-hr Terminology of Wiener
Genetic theory
 That the Rh genes occur at a single
complex locus code for a specific
“agglutinogen” comprised of a
potentially infinite number of “factors.”
Each factor could be demonstrated on the
red cell.
 Each individual factor is detectable by its
own specific antibody

Weiner System
Genes Agglutinogen Factors
R° Rho Rho, hr’, hr”
R1 Rh1 Rho,rh’, hr”
R2 Rh2 Rho, hr’, rh”
Rz Rhz Rho, rh’, rh”
R rh’ hr’, hr”
r’ rh’ rh’, hr”
r” rh” hr’, rh”
ry rhy rh’, rh”

CDE Terminology of Fisher and Race


Genetic theory
 That there are three closely linked gene
loci, each of which has allelic pairs
 Recognized that d is an amorph
 Eight possible combinations of Fisher’s
six genes, in descending order of
frequency, CDe, cde, cDE,cDe, Cde,
cdE, CDE and CdE
 It is currently believed that the Rh genes
occupy many mutational sites on the
chromosome

Fisher-Race
Gene Antigens
Complex
Dce D,c,e
DCe D,C,e
DcE D,c,E
DCE D,C,E
dce c,e
dCe C,e
dcE c,E
dCE C,E
Factor (Ag) Antigen Agglutinogens
Rh0 = D Rh1 =DCē Rhz=DCE
rh’= C Rh2 =DE Rho = Dce
rh”= E rh =ce rh’ = Ce
hr’= c rh” = cE rhy= CE
hr” = e
Qualitative and Quantitative Variation of
Antigens
Diminished Expression of D
 Term Weak D (formerly called Du) is
used to describe diminished D
expression-A red cell sample carrying D
antigen detectable only by application of
indirect antihuman globulin with potent
IgG anti-D sera.
Three mechanisms of Weak D (Du)
High-Grade Weak D (Du) – position
effect or gene interaction effect
 Most often results from gene interaction,
or from a position effect exerted by
another Rh gene
 Genotype CDe/Cde may exhibit
weakened expression of D because of a
depressing effect by Cde on the D that is
the product of CDe.
 Effect possibly aggravated by the
presence of C in both gene complexes.
 Condition is not inheritable
 Individuals do not form anti-D

Low-Grade Weak D (Du) – Inherited


weakened expression of D
 Cells do not agglutinate directly by anti-
D sera, at least when tests are performed
in tubes, even after incubation
 Seen most frequently in Blacks carrying
a variant of Ro

Subdivision of D (D “Mosaic”)
 In rare occurrences, a person who is D-
positive or Weak D (Du) - positive may
make an alloantibody appearing to have
anti-D specificity.
 Believed that the D antigen is comprised
of a mosaic genetically determined
subunits.
 Four individual determinants were
recognized–RhA, RhB, RhC, and RhD.
 Absence of one or more of these would
not necessarily be recognized on testing
the cells with most anti-D sera, but the
individual would be susceptible to
producing antibody to the missing
component.
 The antibody formed is indistinguishable
from anti-D, except that it is nonreactive
with the patient’s own cells, and with
other rare bloods that similarly lack the
relevant subunit.

 Some rare alleles do occur such as: CW,


f(ce), rhi (Ew),G, etc

Some Practical Considerations


 Immunoglobulin Classes IgM and IgG
 Most Rh antibodies are not saline-
reactive, except anti-E (rh”) and anti-CW
(which often react in all phases of
testing)
 Antibodies to Rh antigens are most
commonly IgG
Disease states
 Warm autoimmune hemolytic anemia –
the autoantibodies implicated
demonstrate specific with the Rh system
 Many cases of severe hemolytic disease
of the fetus and newborn- caused by anti-
Rh0 (D)
 Hemolytic transfusion reactions have
been attributed to all antibodies of the Rh
system

Testing for Antigens of the Rh Blood


Group System
Overview
 D- The most important blood group
antigen in everyday blood bank routine,
after A and B
 D is powerfully immunogenic -50% of
D-negative recipients who receive a
single unit of D-positive blood will have
an immune response
 After D, The order of immunogenicity
is:c>E>C>e
 Anti-D may be formed by D-negative
women as a result of feto-maternal
immunization during pregnancy.
 Immunization to D can be prevented in
many cases by administering Rh immune
globulin to Rh-negative women within
72 hours of delivering a D-positive or
Weak D (Du) –positive infant.
 Testing for the other antigens of the Rh
system is neither justified nor practical as
a matter of daily routine.
 Testing for D can either by performed by
the slide or tube method.
Tube Testing for D
 A low concentration of cells is required
(3 to5%)
 Low-grade Weak D (Du) cells do not
agglutinate directly
 High-grade Weak D (Du) cells or even
cells possessing a slightly weaker-than –
average expression of D may give or
equivocal reactions on immediate spin,
but show strong and definite
agglutination after 5 to 15 minutes of
incubation at 370C.
 Patients whose red cells show strong and
definite direct agglutination (before the
antiglobulin phase) should be regarded
as D-positive and be given D- positive
blood.

Weak D (Du) Test


 Involves using high-protein anti-D sera
and then performing an antiglobulin test
after washing the cells.
 Must be performed on all apparent D-
negative donor blood to prevent a Weak
D (Du) –positive unit from being
classified as D-Negative and being
transfused into a D-negative recipient.
 AABB Standards do not require that
recipients be tested for Weak D (Du), but
many hospitals prefer to know when
their patients are Weak D (Du )-positive
 Also frequently carried out on the red
cells of D-negative women who have just
delivered a D-Positive infant and is read
microscopicallyas means of recognizing
and roughly quantitating any fetal D-
positive cells present
Interpretation:
 The cells are Weak D (Du) - positive if:
oThe cells are not agglutinated directly
by the anti-D serum
oAre agglutinated at the antiglobulin
phase of the Weak D (Du) test
 There is no agglutination phase of the
test with Rh control reagent (a DAT is
negative)
 Cells should be reported as “Weak D
(Du)-positive”, never as “D-negative
Weak D (Du)-positive”
 In no agglutination at the antiglobulin
phase, the cells may be reported as “D-
negative Weak D (Du)-negative”
Causes of False Reactions
False positives
 The wrong antiserum was inadvertently
used
 An unsuspected antibody of another
specificity is present in the reagent
 Polyagglutinable cells may demonstrate
agglutination with any reagent
containing human serum
 Autoagglutinins and abnormal proteins
in the test sample may cause false
positive test results when the cells are
unwashed.
 Reagent vials may be contaminated with
bacteria, with foreign substances, or with
antiserum from another vial.
False negatives
 The wrong antiserum was used
 Antiserum was not added.
 A particular antiserum fails to react with
a variant form of the antigen.
 An antiserum containing antibody that is
predominantly directed at a compound
Rh antigen may fail to give a reliably
detectable reaction with cells carrying
the individual antigens as separate gene
products.(e.g anti-C serum that may react
more with Ce than with CE)
 The manufacturer’s instructors were not
followed, and the antiserum was used
incorrectly.
 Unduly hard shaking in resuspending the
cell button may disperse weak
agglutination.
 Immunoglobulin in an antiserum may
deteriorate due to contamination or
improper storage.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy